Leontine Sandforth, clinical scientist at the IDM, was accepted into the DFG funded "Medical Innovation through Interdisciplinarity Clinician Scientist" program

The MINT-CS program promotes medical innovation through interdisciplinarity by fostering the development of scientifically and clinically competent physicians in key areas of translational research at the Faculty of Medicine and in areas that are currently underrepresented for clinical scientists.

In particular, the MINT-CS program aims to address issues in the key clinical areas of oncology, clinical neuroscience and diabetes/vascular medicine, utilizing the excellent cross-sectional research platforms. Other disciplines (e.g. surgical disciplines, general medicine) will be specifically included in order to promote new fields of innovation and broaden the impact of our program. The fellows undergo a qualification curriculum and develop translational research projects in close collaboration between clinical departments and basic science laboratories.

Leontine Sandforth expressed her enthusiasm about her acceptance into the program: “I am looking forward to the prestigious program and the opportunity to investigate the interaction between the brain and peripheral metabolism in more detail in the coming years.”

Andreas Birkenfeld, Medical Director of Diabetology, Endocrinology, and Nephrology at the University Hospital Tübingen and Head of the IDM, adds: “We are very pleased and would like to congratulate Ms. Sandforth on this great success. The program provides the right incentives and enables young scientists to combine clinical research with specialist training in line with our DZD program. This is of great importance for Germany as a research location.”

The MINT-CS program is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).

More informations about the program can be found at the DFG.